Sanofi: Qfitlia Approval A Bright Spot As Landscape Darkens For European Pharma
Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.
DNA repair protein's unexpected structure may lead to new cancer treatments
A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and ...
Unlocking nature's code: Researchers draw parallels between AI models and genetic encoding
In a new paper published in the journal Trends in Genetics researchers from the University of Vermont and Trinity College ...
eLife23h
MMP21 behaves as a fluid flow transported morphogen to impart laterality during development
Laboratory of Human Genetics & Therapeutics, Smart Health Initiative, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST ...
AZoLifeSciences on MSN14h
Scientists Build Live African Swine Fever Virus From Synthetic DNA Using CRISPR
Cas9, scientists reconstitute live African swine fever virus from synthetic genomes, accelerating vaccine development for ...